US-based Novavax, Inc. and SK bioscience, Co. Limited, a vaccine business subsidiary of Korea-based SK Group, have annou...
ABL Bio, Inc., a South Korea-based clinical-stage biotech developing bispecific antibody technology for immuno-oncology ...
The Centre for Breakthrough Medicines (CBM), based in the US, has received $350 million in equity financing from South K...
LISCure Biosciences Inc., a South Korea-based biotech startup, has executed a research collaboration agreement with US b...
South Korea-based startup Astrogen and Paris-based firm Iktos have announced a research collaboration to use A...
BIORCHESTRA and SK Biopharmaceuticals, based in South Korea, have forged a partnership to research and develop new ...
South Korea-based GC Cell and Indian firm Rivaara Immune have entered into an exclusive licensing agreement, pursuant to...
South Korea-based startup TODOC has developed an artificial cochlear implant 'SULLIVAN'. Based on the vision of co...
iMediSync, a leading AI-driven early detection and therapeutic platform for optimal brain health from Seoul, South ...
ImmuneOncia Therapeutics, Inc., a clinical-stage, immuno-oncology startup in South Korea, has announced that a Memorandu...
Novavax, Inc. and SK bioscience, Co. Limited, a vaccine business subsidiary of Korea-based SK Group, have announced the ...
Curocell, currently on PhaseⅠCAR-T Therapy clinical trial with CRC01 (anbalcabtagene autoleucel), has recently broken ...
Norway-based CEPI, the Coalition for Epidemic Preparedness Innovations, and South Korean firm SK bioscience (SK) have an...
Prestige BioPharma (PBP), a Singapore-based biopharmaceutical with operations in US and South Korea, has commenced const...
Liquid biopsy, which detects tumor DNAs in the blood, is not only more convenient than the biopsy that requires collecti...
American firm Moderna has announced that the Ministry of Food and Drug Safety of Korea (MFDS) has issued a marketing aut...
South Korea-based Samsung Biologics continues its strategic biopharmaceutical manufacturing collaboration with AstraZene...
HDT Bio Corp., a US-based developer of immunotherapies for oncology and infectious diseases, and Korean biotech Quratis ...
